Derivative exercise or conversion — not an open-market buy.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director sold ~$103K of HALO shares in the open market
Traded May 1, 2026 · Filed May 5, 2026
- ~$103K
- Reported value · 1,625 sh @ $63.48
- 38K
- Holds after · shares reported
- +69.3%
- stock since the trade · S&P 500 +7.5%, $63.96 → $108.31 on Oct 5
Why it stands out
A board member of Halozyme sold $103K of Halozyme shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- May 1, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- May 5, 2026
Director$100K–$500KPre-arranged plan referenced
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$103,155
Shares × reported transaction price
- Timing vs results
73 days after results of Feb 17, 2026, 10 days before results of May 11, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results